Drug and therapeutics committees: the relationships among structure, function, and effectiveness
R J Plumridge1, J U Stoelwinder, T D Rucker
1Fremantle Hospital, Western Australia.
This study on Australian hospital drug and therapeutics committees (DTCs) found no link between structural factors and effectiveness. Further research into cultural variables is needed to improve DTC performance.
Area of Science:
- Health Services Research
- Pharmacy Practice
- Hospital Administration
Background:
- Drug and Therapeutics Committees (DTCs) are crucial for rational drug use in hospitals.
- Assessing the effectiveness of DTCs and identifying improvement factors is essential for healthcare quality.
- Previous studies often assumed a link between DTC structure and effectiveness.
Purpose of the Study:
- To evaluate the effectiveness of DTCs in Australian hospitals.
- To identify factors influencing DTC effectiveness.
- To recommend strategies for enhancing DTC performance.
Main Methods:
- A national study involving questionnaires sent to 184 hospital directors of pharmacy and 53 DTC chairpersons.
- Analysis of DTC structural variables including membership, chairperson, secretary, meeting frequency, and decision-making functions.
- Comparison of pharmacist and chairperson perceptions regarding DTC weaknesses and required resources.
Main Results:
- No statistically significant association was found between DTC structural variables (e.g., objectives, chairperson, meeting frequency, hospital size) and the outcomes of DTC activities.
- Perceptions of DTC weaknesses and necessary resources differed significantly between pharmacists and DTC chairpersons.
- The study challenges common assumptions about the relationship between DTC structure and its effectiveness.
Conclusions:
- The effectiveness of Drug and Therapeutics Committees may not be solely determined by structural variables.
- Further investigation into both structural and cultural factors is required to understand and improve DTC effectiveness.
- Recommendations for enhancing DTC performance should consider a broader range of influencing elements beyond organizational structure.
More Related Videos
05:28A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction
Published on: August 27, 2019
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Related Concept Videos
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Biopharmaceutics and Pharmacokinetics: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Therapeutic Drug Monitoring: Overview and Classification
